SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326732-23-000026
Filing Date
2023-08-03
Accepted
2023-08-03 17:28:45
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20230630.htm   iXBRL 10-Q 1093933
2 EX-10.1 xncr-20230630xexx101.htm EX-10.1 23182
3 EX-31.1 xncr-20230630xexx311.htm EX-31.1 10219
4 EX-31.2 xncr-20230630xexx312.htm EX-31.2 10041
5 EX-32.1 xncr-20230630xexx321.htm EX-32.1 6382
  Complete submission text file 0001326732-23-000026.txt   6167029

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20230630.xsd EX-101.SCH 36117
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xncr-20230630_cal.xml EX-101.CAL 56298
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xncr-20230630_def.xml EX-101.DEF 220385
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20230630_lab.xml EX-101.LAB 600126
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20230630_pre.xml EX-101.PRE 402487
57 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20230630_htm.xml XML 908926
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 231141347
SIC: 2834 Pharmaceutical Preparations